<DOC>
	<DOC>NCT00385320</DOC>
	<brief_summary>The purpose of this study is to test how infants respond to different strengths of the human rotavirus vaccine.</brief_summary>
	<brief_title>Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months</brief_title>
	<detailed_description />
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy male or female infant between, and including, 6 and 12 weeks of age born after a gestation period of 36 to 42 weeks or a birth weight of &gt;2000g. Written informed consent obtained from the parent or guardian of the subject. Planned administration of oral polio vaccine during the period starting from 2 weeks before each dose of study vaccine(s) and ending 2 weeks after. Any confirmed or suspected immunosuppressive or immunodeficient condition, including human immunodeficiency virus (HIV) infection History of diphtheria, tetanus, pertussis, Hib disease and/ or hepatitis B. Previous vaccination against diphtheria, tetanus, pertussis, and/or Haemophilus influenzae type b. History of allergic disease Any clinically significant history of chronic gastrointestinal disease including any uncorrected congenital malformation of the GI tract or other serious medical condition as determined by the investigator. Gastroenteritis within 7 days preceding the study vaccine administration (warrants deferral of the vaccination) Previous confirmed occurrence of RV GE. Household contact with an immunosuppressed individual or pregnant women. Administration of immunoglobulins and/or blood products since birth or planned administration during the study period</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>